
ICU Medical (ICUI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ICU Medical (ICUI) emitió su última guía sobre agosto 6, 2026 para fiscal year 2026. La compañía estimó unas ganancias por acción en el rango de $8.6 - $9, en comparación con una estimación de consenso de EPS de $7.83.
En comparación con la previsión anterior, ICU Medical elevado redujo su previsión de BPA desde un rango anterior de $7.75 - $8.45.
ICU Medical ha emitido 14 actualizaciones de orientación entre el noviembre 7, 2022 y el agosto 6, 2026. During this period, the company raised its outlook 7 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.82 | $1.67 | $1.54 | $1.31 |
| Actual | $2.37 | $1.97 | $1.91 | $2.03 |
| Surprise | +30.2% | +18.0% | +24.0% | +55.0% |
| Revenue | ||||
| Estimate | $534.0M | $528.9M | $536.3M | $512.7M |
| Actual | $551.7M | $530.2M | $540.7M | $537.0M |
| Surprise | +3.31% | +0.25% | +0.82% | +4.74% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.06 | $2.15 | $1.72 | $1.95 |
| Revenue | ||||
| Consensus | $553.8M | $562.2M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $2.37 | $1.82 | 30.2 % |
| Q1 | May 7, 2026 | $1.97 | $1.67 | 18.0 % |
| Q4 | Feb 19, 2026 | $1.91 | $1.54 | 24.0 % |
| Q3 | Nov 6, 2025 | $2.03 | $1.31 | 55.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $551.70M | $534.02M | 3.31 % |
| Q1 | May 7, 2026 | $530.20M | $528.88M | 0.25 % |
| Q4 | Feb 19, 2026 | $540.70M | $536.31M | 0.82 % |
| Q3 | Nov 6, 2025 | $536.99M | $512.67M | 4.74 % |